2018 American Transplant Congress » Poster Session B: Liver: Hepatocellular Carcinoma and Other Malignancies

Date: Sunday, June 3, 2018

Time: 6:00pm-7:00pm

Location: Hall 4EF

Session Type: Poster Session

Meeting: 2018 American Transplant Congress

6:00pm-7:00pm: A Long-Term Experience with Expansion of Milan Criteria for Liver Transplant Recipients

S. Commander,¹ B. Shaw,¹ L. Washburn,² D. Yoeli,² A. Rana,² J. Goss.²

6:00pm-7:00pm: Advanced Liver Care and Salvage Transplantation Improves Outcomes for Patients with Cirrhosis Requiring Abdominal General Surgical Procedures

D. Milgrom,¹ N. Valsangkar,¹ J. Kays,¹ T. Liang,¹ J. Butler,¹ C. Kubal,¹ M. Maluccio,¹ A. Tector,² L. Koniaris.¹

6:00pm-7:00pm: Cost Analysis of Loco-Regional Bridging Therapy for Hepatocellular Carcinoma: A National Study

M. Nazzal,¹ R. Ouseph,¹ X. Huiling,¹ M. Schnitzler,¹ C. Varma,¹ H. Randall,¹ J. Tuttle-Newhall,² D. Axelrod,³ K. Lentine.¹

6:00pm-7:00pm: Impact of Mammalian Target of Rapamycin Inhibitors on Hepatocellular Carcinoma Recurrence after Liver Transplant

N. Hendon,¹ D. Salerno,¹ C. Sammons,¹ K. Halazun.²

6:00pm-7:00pm: Intention to Treat Outcomes of Patients with Hepatocellular Carcinoma Downstaged to within Milan

P. Tabrizian,¹ M. Holzner,¹ J. Emond,² S. Florman,¹ R. Brown,² M. Schwartz,¹ K. Halazun.²

6:00pm-7:00pm: Liver Transplantation for Hepatocellular Carcinoma Outperform Other Populations in the New Hepatitis C Era

A. Alsina,¹ A. Athienitis,² J. Buggs,¹ E. Fallon,³ E. Parkinson,³ C. Albers,³ N. Kemmer.³

6:00pm-7:00pm: Liver Transplantation for Locally Advanced Intrahepatic Cholangiocarcinoma Treated with Neoadjuvant Therapy: A Pilot Cohort Study

K. Lunsford,¹ M. Javle,² K. Heyne,¹ R. Shroff,² R. Hassan Ali,² C. Mobley,¹ D. Victor,¹ A. Kaseb,² T. Aloia,² C. Conrad,² X. Li,¹ H. Monsour,¹ A. Gaber,¹ J-.N. Vauthey,² R. Ghobrial.¹

6:00pm-7:00pm: Locoregional Treatments before Liver Transplantation for Hepatocellular Carcinoma: A Cohort Study from the European Liver Transplant Registry

H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, P. De Simone, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.

6:00pm-7:00pm: Neutrophil to Lymphocyte Ratio (NLR) Does Not Predict Outcomes after Liver Transplant (LT) for Hepatocellular Carcinoma (HCC)

E. Harding-Theobald, N. Mehta, F. Yao.

6:00pm-7:00pm: Prediction of Hepatocellular Carcinoma Recurrence Following Liver Transplantation Using Combined Differential Gene Expression, Copy Number Variation and Somatic Mutation Analysis

A. Humar,¹ P. Liu,² J. Luo,³ M. Nalesnik,³ A. Singhi,³ G. Tseng,² G. Michalopoulos.³

6:00pm-7:00pm: Predictive Value of mRECIST in HCC Response to the Neoadjuvant Locoregional Therapies and Prognosis Affected by the Peak AFP Level before Liver Transplantation

M. Xu,¹ T. Fraum,² S. Garcia-Aroz,¹ N. Vachharajani,¹ N. Saad,³ K. Fowler,² Y. Lin,¹ W. Chapman.¹

6:00pm-7:00pm: Prognostic Value and Biological Significances of Five Long Non-Coding RNAs in Hepatocellular Carcinoma

Y. Hou,¹ Z. Yu,² N. Tam,¹ S. Huang,¹ J. Yang,¹ L. Wu,¹ Y. Ma,¹ X. He.¹

6:00pm-7:00pm: Radiation Exposure to the Transplant Surgeon: A Case Study of Recent Yttrium-90 Treatment in an Explanted Liver

M. Decoteau,¹ P. Lewis,¹ S. Steuterman,² R. Schaffer,¹ J. Fisher,¹ J. Case,¹ C. Marsh.¹

6:00pm-7:00pm: Risk Factors of De Novo Malignancies after Liver Transplantation

M. Altieri,¹ O. Seree,² J. Dumortier,³ GREF2 Groupe de Recherche Français en Greffe de Foie.

6:00pm-7:00pm: T Cell Lineage Imbalance and Regulatory Immune Populations in HCC Patients Undergoing Downstaging While Waitlisted for Liver Transplantation

P. Thevenot,¹ K. Nunez,¹ T. Sandow,² J. Gimenez,² J. Gonzalez-Rosario,¹ M. Patel,¹ A. Alfadhli,¹ D. Wyczechowska,³ A. Cohen.¹

6:00pm-7:00pm: TP53 Mutations Lead to Increased Transcription of Circular RNAs in Exosomes Enhancing Tumor Invasiveness in Hepatocellular Carcinoma Bases on Bioinformatics Analysis

Z. Yu, Y. Hou, R. Wang, X. Huang.

6:00pm-7:00pm: Tregs Expression Predicts Prognosis in Patients with Hepatocellular Carcinoma

A. Baquerizo,¹ V. Vavinskaya,² C. Frenette,¹ M. Nelson,¹ R. Schaffer,¹ J. Fisher,¹ L. Sher,³ B. Madani,¹ P. Pockros,¹ C. Marsh.¹

6:00pm-7:00pm: Utility of Combining Stereotactic Body Radiation Therapy (SBRT) to Transarterial Chemoembolization as Destination Therapy for Hepatocellular Cancer (HCC) within Milan Criteria

A. Murali, K. Soota, M. Karwal, T. Tanaka, J. Dunkelberg, M. Voigt.

6:00pm-7:00pm: Validating MORAL in Living Donor Liver Transplantation for Hepatocellular Carcinoma

A. Bhatti, A. Qureshi, N. Khan, M. Butt, A. Waheed, A. Rana, F. Dar.

6:00pm-7:00pm: Vascular Invasion and Survival after Liver Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry

H-.C. Pommergaard, A. Rostved, R. Adam, L. Thygesen, M. Salizzoni, M. Bravo, D. Cherqui, F. Filipponi, K. Boudjema, V. Mazzaferro, O. Soubrane, J. García-Valdecasas, J. Prous, A. Pinna, J. O'Grady, V. Karam, C. Duvoux, A. Rasmussen.

6:00pm-7:00pm: Which Way to Go, Liver Resection or Liver Transplantation for Hepatocellular Carcinoma in Child A Liver Cirrhosis

K. Yoon, K. Lee, S. Hong, J-.H. Cho, J-.M. Lee, N-.J. Yi, K. Suh.

« View all sessions from the 2018 American Transplant Congress